Literature DB >> 2166453

Enhancement of hypoxic pulmonary vasoconstriction by metabolic acidosis in dogs.

P Lejeune1, S Brimioulle, M Leeman, R Hallemans, C Melot, R Naeije.   

Abstract

The effects of HCl infusion on multipoint mean pulmonary arterial pressure (PAP)/cardiac index (CI) plots in pentobarbital-anesthetized dogs whose lungs were ventilated alternately in hyperoxia (fraction of inspired O2 [FIO2], 0.4) and hypoxia (FIO2, 0.1) were investigated. Over the range of CI studied (1 to 5 l.min-1.m-2), hypoxia increased PAP in 22 dogs (responders) and did not affect PAP in 16 other dogs (nonresponders). In eight nonresponders, two repetitions of alternated 0.4 and 0.1 FIO2 exposures did not restore hypoxic pulmonary vasoconstriction (HPV), defined as a hypoxia-induced increase in PAP at a given flow. Intravenous infusion of 2 M HCl (2 mmol.kg-1.h-1) decreased arterial pH from normal to around 7.20 in eight responders and eight nonresponders. This metabolic acidosis increased PAP at all levels of CI in hyperoxia and in hypoxia in all the dogs, enhanced HPV in the responders, and restored HPV in the nonresponders. In eight responders, 2 M HCl infusion (2 mmol.kg-1.h-1) together with a 7% sodium bicarbonate infusion (adjusted to maintain arterial pH unchanged) did not affect hyperoxic or hypoxic PAP/CI plots. Pretreatment with 1 g acetylsalicylic acid iv (6 dogs) did not affect the pulmonary vasoreactivity to HCl-induced (2 M HCl, 2 mmol.kg-1.h-1) metabolic acidosis. It was concluded that in intact dogs: 1) metabolic acidosis enhances HPV; 2) at the given dose, HCl does not produce pulmonary vascular effects unrelated to the circulating blood pH; and 3) it is unlikely that the pulmonary vasoreactivity to metabolic acidosis is mediated by products of the cyclooxygenase pathway.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2166453     DOI: 10.1097/00000542-199008000-00012

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  9 in total

1.  Pulmonary vasodilation by acetazolamide during hypoxia: impact of methyl-group substitutions and administration route in conscious, spontaneously breathing dogs.

Authors:  Philipp A Pickerodt; Roland C Francis; Claudia Höhne; Friederike Neubert; Stella Telalbasic; Willehad Boemke; Erik R Swenson
Journal:  J Appl Physiol (1985)       Date:  2014-01-30

2.  Respective roles of hypercapnia and acidosis in acute distress respiratory syndrome.

Authors:  Armand Mekontso Dessap; Segolène Gendreau; Antoine Vieillard-Baron
Journal:  Intensive Care Med       Date:  2022-05-05       Impact factor: 41.787

3.  Adaptive lung ventilation (ALV) during anesthesia for pulmonary surgery: automatic response to transitions to and from one-lung ventilation.

Authors:  N Weiler; B Eberle; W Heinrichs
Journal:  J Clin Monit Comput       Date:  1998-05       Impact factor: 2.502

Review 4.  Diagnostic workup, etiologies and management of acute right ventricle failure : A state-of-the-art paper.

Authors:  Antoine Vieillard-Baron; R Naeije; F Haddad; H J Bogaard; T M Bull; N Fletcher; T Lahm; S Magder; S Orde; G Schmidt; M R Pinsky
Journal:  Intensive Care Med       Date:  2018-05-09       Impact factor: 17.440

Review 5.  Hypoxic pulmonary vasoconstriction.

Authors:  J T Sylvester; Larissa A Shimoda; Philip I Aaronson; Jeremy P T Ward
Journal:  Physiol Rev       Date:  2012-01       Impact factor: 46.500

Review 6.  Pulmonary vascular and right ventricular dysfunction in adult critical care: current and emerging options for management: a systematic literature review.

Authors:  Laura C Price; Stephen J Wort; Simon J Finney; Philip S Marino; Stephen J Brett
Journal:  Crit Care       Date:  2010-09-21       Impact factor: 9.097

7.  Respiratory and metabolic acidosis correction with the ADVanced Organ Support system.

Authors:  Aritz Perez Ruiz de Garibay; John A Kellum; Johannes Honigschnabel; Bernhard Kreymann
Journal:  Intensive Care Med Exp       Date:  2019-09-18

Review 8.  Severe pulmonary hypertension and right ventricular failure.

Authors:  Ajay Kumar; Praveen Kumar Neema
Journal:  Indian J Anaesth       Date:  2017-09

Review 9.  Health risk of travel for chronic kidney disease patients.

Authors:  Yoshitaka Furuto; Mariko Kawamura; Akio Namikawa; Hiroko Takahashi; Yuko Shibuya
Journal:  J Res Med Sci       Date:  2020-03-18       Impact factor: 1.852

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.